A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin’s lymphoma

World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

Nancy L. Harris, Elaine S. Jaffe, J Diébold et al. · Journal of Clinical Oncology · 1999 · 3.3K citations

Medicine, Hematology, Pathology +17

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment

Cheson Bd, J M Bennett, Michael R. Grever et al. · Blood · 1996 · 1.8K citations

Medicine, Hematology, Oncology +12

Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia

Bercedis L. Peterson, Frederick R. Appelbaum, Jonathan E. Kolitz et al. · New England Journal of Medicine · 2000 · 1K citations · Full text

Medicine, Oncology, Pharmacotherapy +10

p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias

H. Döhner, Konstanze Fischer, Martin Bentz et al. · Blood · 1995 · 732 citations · Full text

Medicine, Molecular Biology, Oncology +17

Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)

Olivier Hermine, Corinne Haïoun, Éric Lepage et al. · Blood · 1996 · 417 citations · Full text

Medicine, Oncology, Pathology +11